Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Angiodynamics Inc (ANGO)

Angiodynamics Inc (ANGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 428,936
  • Shares Outstanding, K 37,626
  • Annual Sales, $ 270,630 K
  • Annual Income, $ 61,340 K
  • 60-Month Beta 0.69
  • Price/Sales 1.23
  • Price/Cash Flow 7.63
  • Price/Book 0.75

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 02/29/20
See More
  • Average Estimate -0.03
  • Number of Estimates 2
  • High Estimate -0.03
  • Low Estimate -0.03
  • Prior Year 0.19
  • Growth Rate Est. (year over year) -115.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.20 +1.70%
on 02/28/20
14.41 -20.96%
on 02/06/20
-2.63 (-18.76%)
since 01/28/20
3-Month
11.20 +1.70%
on 02/28/20
17.24 -33.93%
on 01/07/20
-4.09 (-26.42%)
since 11/27/19
52-Week
11.20 +1.70%
on 02/28/20
25.48 -55.30%
on 04/01/19
-11.02 (-49.17%)
since 02/28/19

Most Recent Stories

More News
AngioDynamics to Present at Two Investor Conferences in March

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will present...

ANGO : 11.45 (+0.44%)
Angiodynamics In Down 34.3% Since SmarTrend Downtrend Call (ANGO)

SmarTrend identified a Downtrend for Angiodynamics In (NASDAQ:ANGO) on August 13th, 2019 at $19.37. In approximately 6 months, Angiodynamics In has returned 34.28% as of today's recent price of $12.73....

ANGO : 11.45 (+0.44%)
Downtrend Call Working As Angiodynamics In Stock Falls 33.1% (ANGO)

SmarTrend identified a Downtrend for Angiodynamics In (NASDAQ:ANGO) on August 13th, 2019 at $19.37. In approximately 6 months, Angiodynamics In has returned 33.12% as of today's recent price of $12.96....

ANGO : 11.45 (+0.44%)
AngioDynamics (ANGO) Down 10.4% Since Last Earnings Report: Can It Rebound?

AngioDynamics (ANGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ANGO : 11.45 (+0.44%)
AngioDynamics Appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has appointed...

ANGO : 11.45 (+0.44%)
Angiodynamics In Shares Down 21.5% Since SmarTrend's Sell Call (ANGO)

SmarTrend identified a Downtrend for Angiodynamics In (NASDAQ:ANGO) on August 13th, 2019 at $19.37. In approximately 5 months, Angiodynamics In has returned 21.48% as of today's recent price of $15.21....

ANGO : 11.45 (+0.44%)
AngioDynamics Launches PATHFINDER I Registry to Evaluate Performance and Clinical Outcomes of the AURYON(TM) Atherectomy System

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced the launch of the...

ANGO : 11.45 (+0.44%)
Angiodynamics In Shares Down 24.9% Since SmarTrend's Sell Call (ANGO)

SmarTrend identified a Downtrend for Angiodynamics In (NASDAQ:ANGO) on August 13th, 2019 at $19.37. In approximately 5 months, Angiodynamics In has returned 24.94% as of today's recent price of $14.54....

ANGO : 11.45 (+0.44%)
Here's Why You Should Hold on to AngioDynamics Stock Now

AngioDynamics (ANGO) retains fiscal 2020 view; VA revenues soft in fiscal Q2.

CERN : 68.70 (-1.70%)
ANGO : 11.45 (+0.44%)
DXCM : 271.97 (-3.38%)
HQY : 71.64 (-3.11%)
AngioDynamics (ANGO) Q2 Earnings Top, Revenues Lag Estimates

AngioDynamics (ANGO) gains from core Oncology business in the fiscal second quarter, reiterates guidance.

CERN : 68.70 (-1.70%)
ANGO : 11.45 (+0.44%)
DXCM : 271.97 (-3.38%)
HQY : 71.64 (-3.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade ANGO with:

Business Summary

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and treatment of peripheral vascular disease. AngioDynamics, Inc. designs, develops, manufactures and markets a broad...

See More

Key Turning Points

2nd Resistance Point 12.18
1st Resistance Point 11.79
Last Price 11.45
1st Support Level 11.18
2nd Support Level 10.96

See More

52-Week High 25.48
Fibonacci 61.8% 20.03
Fibonacci 50% 18.34
Fibonacci 38.2% 16.65
Last Price 11.45
52-Week Low 11.20

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar